Gerald Commissiong & Tollo Health
9 shared events · Importance 3 · Last updated Aug 12, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
Gerald Commissiong: Gerald Commissiong, Interim Co-CEO of Wellgistics, provided key insights into the company's transformative period, strategic direction, and future growth plans.
Tollo Health: Tollo Health's proprietary nutraceutical products, including Forzet, Galectovid, and Tollovid, will be launched through the Health Lives Here app, contributing to Wellgistics's product pipeline.
Jun 01, 2026 · 7 articles
Business
Gerald Commissiong: As CEO of Tollo and interim co-CEO of DataMeds, Commissiong is a key spokesperson and driver of the partnership.
Tollo Health: Tollo Health co-develops the platform and provides products, gaining exposure and distribution through the partnership.
Sep 08, 2026 · 6 articles
Business
Gerald Commissiong: As Interim Co-CEO, Commissiong is the public face of the initiative, and his appearance on Fox Business may boost investor confidence in the company's leadership.
Tollo Health: Tollo Health's medical foods and supplements are central to the initiative, and the planned acquisition could strengthen DataMeds AI's product portfolio.
Aug 05, 2026 · 6 articles
Business
Gerald Commissiong: Gerald Commissiong, Interim Co-CEO of DataMeds AI, is the spokesperson for the rebranding and strategic initiatives.
Tollo Health: Tollo Health is the target of a proposed acquisition by DataMeds AI, which could expand its product offerings and customer base.
Aug 10, 2026 · 13 articles
Business
Gerald Commissiong: Gerald Commissiong, interim co-CEO, is the spokesperson for the launch, representing the company's leadership and strategic direction.
Tollo Health: Tollo Health is the partner that developed Galectovid and sells it through its online store, benefiting from increased distribution and sales.
Aug 27, 2026 · 10 articles
Business
Gerald Commissiong: Gerald Commissiong, Interim Co-CEO of Wellgistics, provided commentary on the strategic rationale behind the name change and the company's vision.
Tollo Health: Tollo Health, an operating company, is being contributed to DataMeds AI by HealthBridge Advisors and has a pending partnership with NFL Alumni Health.
Jun 26, 2026 · 6 articles
Business
Gerald Commissiong: Gerald Commissiong, Interim Co-CEO of DataMeds AI, commented on the website launch, the Helomics acquisition closing, the litigation settlement, and plans to soft launch the Health Lives Here app.
Tollo Health: Tollo Health develops products distributed by DataMeds AI's Corexa Health subsidiary, noted in the company background.
Sep 21, 2026 · 6 articles
Business
Gerald Commissiong: As Interim Co-CEO of DataMEDS, Gerald Commissiong highlighted the strategic importance of the acquisition in expanding into oncology and improving patient outcomes.
Tollo Health: Tollo Health develops products distributed by DataMEDS' subsidiary, and could see synergies with the expanded cancer care services.
Sep 15, 2026 · 7 articles
Business
Gerald Commissiong: Interim Co-CEO of DataMeds AI who publicly framed the settlement as clearing the way for the company's healthcare integration and tokenization strategy.
Tollo Health: Products are distributed through Corexa Health; mentioned only as part of the company description with no direct role in the settlement.
Sep 18, 2026 · 7 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Gerald Commissiong and Tollo Health interact across events, view sentiment trends, and discover connected entities.
Open Dashboard